Evidence map›Paper›PMID 41605117›Full record

ReviewThe International journal on drug policy2026

A comprehensive review of state laws that govern the distribution and possession of drug use equipment in the United States.

Corey S Davis, Michael Abrams, Ashleigh Dennis, Amy Judd Lieberman, Czarina N Behrends

Abstract readReview
In one paragraph

Review in The International journal on drug policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Corey S DavisNetwork for Public Health Law, 7101 York Avenue South, #270 Edina, MN 55435, United States; Department of Population Health, Grossman School of Medicine, New York University Langone, 180 Madison Ave, 4th Floor New York, NY 10016, United States. Electronic address: cdavis@networkforphl.org.
Michael AbramsNetwork for Public Health Law, 7101 York Avenue South, #270 Edina, MN 55435, United States.
Ashleigh DennisNetwork for Public Health Law, 7101 York Avenue South, #270 Edina, MN 55435, United States.
Amy Judd LiebermanNetwork for Public Health Law, 7101 York Avenue South, #270 Edina, MN 55435, United States.
Czarina N BehrendsDepartment of Population Health Sciences, Weill Cornell Medical College, 575 Lexington Ave, New York, NY 10022, United States.

Funding

Expansion of Mail-Delivered Harm Reduction Services in the U.S.R01DA057654 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI BEHRENDS, CZARINA NAVOS · 2022 to 2025
$3.2M
NIDA NIH HHS R01 DA057654
6 · The paper itself

Abstract

The United States continues to experience a large amount of drug-related harm, including high rates of both overdose mortality and harms associated with lack of access to new drug use equipment such as syringes and pipes. These harms include the spread of bloodborne disease as well as endocarditis, osteomyelitis, and other skin and soft tissue infections. Laws that prohibit or restrict access to drug use equipment may increase these harms. This manuscript provides a comprehensive legal review of laws that criminalize or otherwise restrict the distribution and possession of equipment for both injecting and inhaling drugs from both syringe services programs and other venues. We also report novel data on the severity of penalties associated with violations of prohibitions on the above activities. We find great heterogeneity in these laws. The free distribution of injection equipment for illicit drug use is permitted in 19 states, and the free distribution of smoking equipment is permitted in 14 states. The possession of injection equipment is permitted in 21 states, and the possession of smoking equipment in 15. Where possession or distribution of drug use equipment is prohibited or restricted, we found large differences in the penalties imposed for violations. There is also wide variation in laws governing the operation of syringe services programs, which are permitted in some form in 40 states but often highly regulated. We suggest that states evaluate and, where indicated, remove legal barriers to these supplies.

Indexed as

Needle-Exchange ProgramsSubstance Abuse, IntravenousHumansIllicit DrugsState GovernmentSyringesUnited StatesIllicit DrugsBloodborne diseaseInjection drug useLawParaphernaliaPolicySyringe services programs

Identifiers

PMID41605117
PMCPMC13459728

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.